Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C25H29N3O8 |
Molecular Weight | 499.5131 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CCCCN1C(=O)OC[N+]2=CC=CC(=C2)C(=O)N[C@@H](CO)C([O-])=O)[C@H](C(=O)OC)C3=CC=CC=C3
InChI
InChIKey=UBZPNQRBUOBBLN-PWRODBHTSA-N
InChI=1S/C25H29N3O8/c1-35-24(33)21(17-8-3-2-4-9-17)20-11-5-6-13-28(20)25(34)36-16-27-12-7-10-18(14-27)22(30)26-19(15-29)23(31)32/h2-4,7-10,12,14,19-21,29H,5-6,11,13,15-16H2,1H3,(H-,26,30,31,32)/t19-,20+,21+/m0/s1
Molecular Formula | C25H29N3O8 |
Molecular Weight | 499.5131 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 13:40:47 UTC 2023
by
admin
on
Sat Dec 16 13:40:47 UTC 2023
|
Record UNII |
0H8KZ470DW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
1729
Created by
admin on Sat Dec 16 13:40:47 UTC 2023 , Edited by admin on Sat Dec 16 13:40:47 UTC 2023
|
||
|
FDA ORPHAN DRUG |
878522
Created by
admin on Sat Dec 16 13:40:47 UTC 2023 , Edited by admin on Sat Dec 16 13:40:47 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2014450-84-9
Created by
admin on Sat Dec 16 13:40:47 UTC 2023 , Edited by admin on Sat Dec 16 13:40:47 UTC 2023
|
ALTERNATIVE | |||
|
300000005913
Created by
admin on Sat Dec 16 13:40:47 UTC 2023 , Edited by admin on Sat Dec 16 13:40:47 UTC 2023
|
PRIMARY | |||
|
1996626-29-9
Created by
admin on Sat Dec 16 13:40:47 UTC 2023 , Edited by admin on Sat Dec 16 13:40:47 UTC 2023
|
PRIMARY | |||
|
0H8KZ470DW
Created by
admin on Sat Dec 16 13:40:47 UTC 2023 , Edited by admin on Sat Dec 16 13:40:47 UTC 2023
|
PRIMARY | |||
|
2562176
Created by
admin on Sat Dec 16 13:40:47 UTC 2023 , Edited by admin on Sat Dec 16 13:40:47 UTC 2023
|
PRIMARY | |||
|
10916
Created by
admin on Sat Dec 16 13:40:47 UTC 2023 , Edited by admin on Sat Dec 16 13:40:47 UTC 2023
|
PRIMARY | |||
|
134823895
Created by
admin on Sat Dec 16 13:40:47 UTC 2023 , Edited by admin on Sat Dec 16 13:40:47 UTC 2023
|
PRIMARY | |||
|
C166420
Created by
admin on Sat Dec 16 13:40:47 UTC 2023 , Edited by admin on Sat Dec 16 13:40:47 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
EXCRETED UNCHANGED |
URINE
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
EXCRETED UNCHANGED |
FECAL
|
||
|
BINDER->LIGAND |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
FASTED STATE PHARMACOKINETIC PHARMACOKINETIC |
|
||
Biological Half-life | PHARMACOKINETIC |
|
IN HEALTHY ADULT SUBJECTS PHARMACOKINETIC |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
after AZSTARYS administration PHARMACOKINETIC |
|
||